Dr. James A. Staman, MD

Dr. Staman practices at Retina Group of Florida in Brooksville, Florida.

Dr. Staman's NPI, 1841290657, was assigned on July 22, 2005. Dr. Staman graduated from Lewis Katz School of Medicine in 1974. Dr. Staman holds Florida license ME0030868.

Dr. Staman's primary practice is Retina Group of Florida, at 11373 Cortez Blvd, Brooksville, FL 34613 in Hernando County. The practice phone is (954) 776-6880.

Dr. Staman's primary practice is Retina Group of Florida in Brooksville, Florida. Dmand AI also links Dr. Staman to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Staman practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Staman's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Staman is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Staman's licenses on file in 3 states: Florida, Georgia and Pennsylvania.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eyelid inflammation, glaucoma and glaucoma surgery among the conditions Dr. Staman treats.

CMS data shows 29,697 Medicare services from Dr. Staman across 23 procedure codes in 2024, for 1,390 Medicare patients. Medicare paid $4,058,541 for them.

CMS counts 1,390 Medicare patients who saw Dr. Staman in 2024. The largest group is 75 to 84, with 535 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Staman's median patient age at 73, with 55% women.

In 2024, Dr. Staman wrote 2,369 Medicare Part D claims for 588 patients. 58% of them were for generic drugs. CMS names the drug for 2,285 of them, across 24 drugs with 11 or more claims each, at $842,826 in total drug cost. In 2023, CMS named 2,393 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Staman for performance year 2024, reported as part of a group. Dr. Staman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Staman. Dr. Staman has published most often in Tijdschr Diergeneeskd. Dr. Staman's most frequent co-authors are John P. Barletta, MD and Curtis E. Margo, MD.

CMS Open Payments shows 41 general payments to Dr. Staman from 17 drug and device companies from 2016 to 2025. Acquisitions make up the largest share, 44% of the total. US Retina LLC paid the most, $2,792.

Dmand AI lists 1 award for Dr. Staman.

Dr. Staman graduated from Lewis Katz School of Medicine in 1974. Dr. Staman is a member of AAO.

Dr. Staman is in network with 20 carriers, including Elevance, Excellus BlueCross BlueShield and Aetna. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.